glp-1 agonist drugs Drugs: Fighting Diabetes and Weight Gainπ - General Letter: Association Between Incretin Mimetics
Description
That does not mean these injuries are not real or serious
Founder: Paige Hathaway - fitness personality and brand figure
Young: Yeah, tirzepatide got lifted off of the shortage list in, I think, late 2024, and then semaglutide followed in 2025
FDA labeling includes a boxed warning regarding thyroid C-cell tumors based on rodent studies, though human relevance remains uncertain
These carry specific FDA-approved indications and extensive clinical trial data
Yes, variants in the GLP1R gene (e.g., rs6923761) have been associated with differences in weight loss response to GLP-1 medications in clinical studies
